Resultados da pesquisa por Autor

1

Somatostatin agonists for treatment of acromegaly

Somatostatin agonists for treatment of acromegaly

Por Ben-Shlomo, Anat, Melmed, Shlomo
Publicado em 2007

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Acromegaly

Por Ben-Shlomo, Anat, Melmed, Shlomo
Publicado em 2008

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Pituitary Somatostatin Receptor Signaling

Pituitary Somatostatin Receptor Signaling

Por Ben-Shlomo, Anat, Melmed, Shlomo
Publicado em 2010

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes

Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes

Por Cooper, Odelia, Ben-Shlomo, Anat, Bonert, Vivien, Bannykh, Serguei, Mirocha, James, Melmed, Shlomo
Publicado em 2010

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

5

Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis

Constitutive Somatostatin Receptor Subtype-3 Signaling Suppresses Growth Hormone Synthesis

Por Eigler, Tamar, Ben-Shlomo, Anat, Zhou, Cuiqi, Khalafi, Ramtin, Ren, Song-Guang, Melmed, Shlomo
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

p21(Cip1) restrains pituitary tumor growth

p21(Cip1) restrains pituitary tumor growth

Por Chesnokova, Vera, Zonis, Svetlana, Kovacs, Kalman, Ben-Shlomo, Anat, Wawrowsky, Kolja, Bannykh, Serguei, Melmed, Shlomo
Publicado em 2008

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

Por Fukuoka, Hidenori, Cooper, Odelia, Ben-Shlomo, Anat, Mamelak, Adam, Ren, Song-Guang, Bruyette, Dave, Melmed, Shlomo
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

Growth hormone is a cellular senescence target in pituitary and nonpituitary cells

Growth hormone is a cellular senescence target in pituitary and nonpituitary cells

Por Chesnokova, Vera, Zhou, Cuiqi, Ben-Shlomo, Anat, Zonis, Svetlana, Tani, Yuji, Ren, Song-Guang, Melmed, Shlomo
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

9

Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response

Constitutive Somatostatin Receptor Activity Determines Tonic Pituitary Cell Response

Por Ben-Shlomo, Anat, Zhou, Cuiqi, Pichurin, Oxana, Chesnokova, Vera, Liu, Ning-Ai, Culler, Michael D., Melmed, Shlomo
Publicado em 2009

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

10

Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth

Senescence Mediates Pituitary Hypoplasia and Restrains Pituitary Tumor Growth

Por Chesnokova, Vera, Zonis, Svetlana, Rubinek, Tami, Yu, Run, Ben-Shlomo, Anat, Kovacs, Kalman, Wawrowsky, Kolja, Melmed, Shlomo
Publicado em 2007

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

11

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor

Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor

Por Liu, Ning-Ai, Jiang, Hong, Ben-Shlomo, Anat, Wawrowsky, Kolja, Fan, Xue-Mo, Lin, Shuo, Melmed, Shlomo
Publicado em 2011

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

In vivo time-lapse imaging delineates the zebrafish pituitary proopiomelanocortin lineage boundary regulated by FGF3 signal

Por Liu, Ning-Ai, Ren, Meina, Song, Jianbo, Ríos, Yesenia, Wawrowsky, Kolja, Ben-Shlomo, Anat, Lin, Shuo, Melmed, Shlomo
Publicado em 2008

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

13

Diminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence

Diminished Pancreatic β-Cell Mass in Securin-Null Mice Is Caused by β-Cell Apoptosis and Senescence

Por Chesnokova, Vera, Wong, Chris, Zonis, Svetlana, Gruszka, Anna, Wawrowsky, Kolja, Ren, Song-Guang, BenShlomo, Anat, Yu, Run
Publicado em 2009

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

14

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors

Por Cooper, Odelia, Mamelak, Adam, Bannykh, Serguei, Carmichael, John, Bonert, Vivien, Lim, Stephen, Cook-Wiens, Galen, Ben-Shlomo, Anat
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

15

Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth

Clusterin and FOXL2 Act Concordantly to Regulate Pituitary Gonadotroph Adenoma Growth

Por Chesnokova, Vera, Zonis, Svetlana, Wawrowsky, Kolja, Tani, Yuji, Ben-Shlomo, Anat, Ljubimov, Vladimir, Mamelak, Adam, Bannykh, Serguei, Melmed, Shlomo
Publicado em 2012

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis

Constitutive Somatostatin Receptor Subtype 2 Activity Attenuates GH Synthesis

Por Ben-Shlomo, Anat, Pichurin, Oxana, Khalafi, Ramtin, Zhou, Cuiqi, Chesnokova, Vera, Ren, Song-Guang, Liu, Ning-Ai, Melmed, Shlomo
Publicado em 2013

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

17

CLINICAL FACTORS ASSOCIATED WITH BIOCHEMICAL ADRENAL-CORTISOL INSUFFICIENCY IN HOSPITALIZED PATIENTS

CLINICAL FACTORS ASSOCIATED WITH BIOCHEMICAL ADRENAL-CORTISOL INSUFFICIENCY IN HOSPITALIZED PATIENTS

Por Ben-Shlomo, Anat, Mirocha, James, Gwin, Stephanie M., Khine, Annika K., Liu, Ning-Ai, Sheinin, Renee C., Melmed, Shlomo
Publicado em 2014

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

18

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease

Por Liu, Ning-Ai, Araki, Takako, Cuevas-Ramos, Daniel, Hong, Jiang, Ben-Shlomo, Anat, Tone, Yukiko, Tone, Masahide, Melmed, Shlomo
Publicado no J Clin Endocrinol Metab (2015)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Por Ben-Shlomo, Anat, Schmid, Herbert, Wawrowsky, Kolja, Pichurin, Oxana, Hubina, Erika, Chesnokova, Vera, Liu, Ning-Ai, Culler, Michael, Melmed, Shlomo
Publicado no Mol Endocrinol (2009)

Obter o texto integral
Obter o texto integral

Artigo

20

Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Por Ben-Shlomo, Anat, Schmid, Herbert, Wawrowsky, Kolja, Pichurin, Oxana, Hubina, Erika, Chesnokova, Vera, Liu, Ning-Ai, Culler, Michael, Melmed, Shlomo
Publicado no Mol Endocrinol (2009)

Obter o texto integral
Obter o texto integral

Artigo